The regional ratio of cholesteryl palmitate to cholesteryl oleate measured by ToF-SIMS as a key parameter of atherosclerosis

Atherosclerosis

Volumn 226, Issue 2, 2013, Pages 378-384

  Lee, Eun Soo ^a   Shon, Hyun Kyong ^b   Lee, Tae Geol ^a,b   Kim, Se Hwa ^a,b   Moon, Dae Won ^a,b  

^a University of Science and Technology (UST)   (South Korea)

^b Korea Research Institute of Standards and Science   (South Korea)

Author keywords

Atherosclerosis; Cell death; Cholesterol ester; Fatty acid; Regional ratio; ToF SIMS

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER; CHOLESTEROL LINOLEATE; CHOLESTEROL OLEATE; CHOLESTEROL PALMITATE; CHOLESTEROL STEARATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL DEATH; CONTROLLED STUDY; DISEASE COURSE; IMAGE ANALYSIS; LIPID DIET; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME OF FLIGHT SECONDARY ION MASS SPECTROMETRY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL ESTERS; DIET, HIGH-FAT; DISEASE PROGRESSION; MALE; MICE; MICE, KNOCKOUT; SPECTROMETRY, MASS, SECONDARY ION;

EID: 84872425719     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.11.003     Document Type: Article

References (31)

1. Schreiner P.J., Morrisett J.D., Sharrett A.R., et al. Lipoprotein[a] as a risk factor for preclinical atherosclerosis. Arterioscler Thromb 1993, 13:826-833.
2. Zhao Y., Ye D., Wang J., et al. Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice. Am J Pathol 2011, 179:1522-1532.
3. Steinbrecher U.P., Parthasarathy S., Leake D.S., et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A 1984, 81:3883-3887.
4. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995, 92:1355-1374.
5. Osterud B., Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev 2003, 83:1069-1112.
6. Schneider J.G., Yang Z., Chakravarthy M.V., et al. Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. J Biol Chem 2010, 285:23398-23409.
7. Hegyi L., Skepper J.N., Cary N.R., et al. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol 1996, 180:423-429.
8. Saam T., Underhill H.R., Chu B., et al. Prevalence of American Heart Association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J Am Coll Cardiol 2008, 51:1014-1021.
9. Zaima N., Sasaki T., Tanaka H., et al. Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesions. Atherosclerosis 2011, 217:427-432.
10. Touboul D., Kollmer F., Niehuis E., et al. Improvement of biological time-of-flight-secondary ion mass spectrometry imaging with a bismuth cluster ion source. J Am Soc Mass Spectrom 2005, 16:1608-1618.
11. Malmberg P., Borner K., Chen Y., et al. Localization of lipids in the aortic wall with imaging TOF-SIMS. Biochim Biophys Acta 2007, 1771:185-195.
12. Mas S., Touboul D., Brunelle A., et al. Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging. Analyst 2007, 132:24-26.
13. Magnusson Y.K., Friberg P., Sjovall P., et al. TOF-SIMS analysis of lipid accumulation in the skeletal muscle of ob/ob mice. Obesity (Silver Spring) 2008, 16:2745-2753.
14. Debois D., Bralet M.P., Le Naour F., et al. In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF-SIMS imaging. Anal Chem 2009, 81:2823-2831.
15. Guo W., Hamilton J.A. Phase behavior and crystalline structures of cholesteryl ester mixtures: a C-13 MASNMR study. Biophys J 1995, 68:2376-2386.
16. Lang P.D., Insull W. Lipid droplets in atherosclerotic fatty streaks of human aorta. J Clin Invest 1970, 49:1479-1488.
17. Small D.M. George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. Arteriosclerosis 1988, 8:103-129.
18. Peng S., Guo W., Morrisett J.D., et al. Quantification of cholesteryl esters in human and rabbit atherosclerotic plaques by magic-angle spinning (13)C-NMR. Arterioscler Thromb Vasc Biol 2000, 20:2682-2688.
19. Zhou J., Lhotak S., Hilditch B.A., et al. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 2005, 111:1814-1821.
20. Boesten L.S., Zadelaar A.S., van Nieuwkoop A., et al. Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice. Atherosclerosis 2009, 207:399-404.
21. Kim S.H., Lee E.S., Lee J.Y., et al. Multiplex coherent anti-stokes Raman spectroscopy images intact atheromatous lesions and concomitantly identifies distinct chemical profiles of atherosclerotic lipids. Circ Res 2010, 106:1332-1341.
22. Ishiyama J., Taguchi R., Akasaka Y., et al. Unsaturated FAs prevent palmitate-induced LOX-1 induction via inhibition of ER stress in macrophages. J Lipid Res 2011, 52:299-307.
23. Gao D., Nong S., Huang X., et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 2010, 285:29965-29973.
24. Listenberger L.L., Ory D.S., Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 2001, 276:14890-14895.
25. Ricchi M., Odoardi M.R., Carulli L., et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol 2009, 24:830-840.
26. Karaskov E., Scott C., Zhang L., et al. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 2006, 147:3398-3407.
27. Daugherty A., Zweifel B.S., Sobel B.E., et al. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis 1988, 8:768-777.
28. Benitez S., Camacho M., Arcelus R., et al. Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL. Atherosclerosis 2004, 177:299-305.
29. Hanasaki K., Yamada K., Yamamoto S., et al. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation. J Biol Chem 2002, 277:29116-29124.
30. Brown J.M., Chung S., Sawyer J.K., et al. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2010, 30:24-30.
31. Brown J.M., Chung S., Sawyer J.K., et al. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation 2008, 118:1467-1475.